Recent Articles

Recent Comments

« | Main | »


By admin | October 18, 2008


Cannabis Digest #19
By Ted Smith

After years of struggling to keep the CBC of C alive, we are preparing to embark into new territory in our attempts to legalize cannabis for medical purposes.  In partnership with the International Hempology 101 Society we are going to create a cannabis research foundation and pharmaceutical company.  These organizations will compliment the work of Hempology 101 and the CBC of C by developing the capacity to generate, critique and encourage cannabis research. 

These organizations will focus upon the effects of eating and topically applying cannabis preparations to help deal with various medical problems.  Research into other impacts of cannabis use on individuals and society will also be an important function of these entities.  The research foundation could secure itself as a primary source of current, accurate information on the medical uses of cannabis as time progresses.  We will be able to respond to media reports on scientific results and prepare literature for students and the public. 

Over time we hope to work with other researchers and students in various ways, allowing the members of the CBC of C the opportunity to participate in the collection of information.  With over 2,300 people suffering from a variety of medical problems already using cannabis products, the CBC of C is one of the best sources of information about this subject in North America.  This is already starting to happen, with the Coo-Aid Society using the club as a source for contact with people recently infected with Hep C.  With the University of Victoria and University of British Columbia employing many researchers in the areas of drug use and medical treatments, we should have no problem attracting interest in the scientific community. 

For several years we have been working on a comparative analysis of cannabis products to prescription drugs.  Early results of this study suggest that we are saving at least $10 in prescription drug costs per day with an average use of $3 in cannabis products, though that could be as high as $25 per day.  These figures suggest we are saving the provincial government $10,000 to $25,000 per day in prescription drug costs withoutconsidering visits to the physician or other medical complications that result from prolonged use of pharmaceuticals. 

While many have studied the medicinal benefits of smoking cannabis and the use of synthetic cannabinoids, whole plant edible and topically applied extracts have not been seriously considered by the research community.  The research foundation and drug company we are forming will work together to study, patent and legalize the production and distribution of the food and skin products of the CBC of C.  While learning how to maximize the medical utility of the plant we will expose the patents and standard operating procedures to the public.  This should stop large, established drug companies from protecting this information from the public with a patent and potentially even affecting the ability of compassion clubs to make these herbal medicines. 

Since these products are technically made with cannabis resin, we have several obstacles to overcome.  The MMAR have no provisions that allow people with ATPs to make cannabis food or skin products, even though they suggest to people that smoking causes more potential health problems than other means of ingestion.  Though this issue could be resolved in court, we plan upon using science to prove that edible and topical cannabis products can provide significant symptom relief.   The term cannabis resin can apply to a wide variety of products and processes by which they are made.  We will start by patenting the standard operating procedures we use to create Ryanol capsules.  

The first study will be regarding the differences between Ryanols made with low-THC hemp, PPS cannabis, a placebo and those used at the CBC of C.  We will patent similar processes for other products as the testing is done.  Eventually we hope to have a facility growing cannabis for research purposes, though that is years down the road.  Given the depth and complexity of this project, we feel it is necessary to hire a full-time staff person to get the job done.  This person will be required to help form an international panel of experts for each institution to help oversee the creation and development of the projects. 

The successful applicant will become the first legal employee of the International Hempology 101 Society.  All pay and benefits will match those of the staff of the CBC of C, which is currently $12/hr, one week paid vacation, 60% sick pay and 50% of dental costs (including children under age 18).  More staff benefits are expected in the future.  We have contracted Luiz Ambiz Inc. to be our accountant, making sure we are paying our taxes while providing transparency for those considering donating to the group.  It will also be useful having an accountant as we create more Hempology 101 products to be sold in stores across North America and on-line.  The board of director will be forming a committee on Oct 14 to help hire and guide the research coordinator.  Applications for the research coordinator will be accepted from Nov 15 to Dec 1.  We will be conducting interviews for the job until Dec 15 at which time we will announce the successful candidate.  The first day on the job for the research coordinator will be Jan 2, 2009.  The addition of a research coordinator to the Hempology 101 team means that we will be able to have more impact nationally than ever.

Topics: Articles, CD-19th | Comments Off

Comments are closed.